Captopril, an ACE inhibitor drug, seems to be associated with a higher rate of adverse pulmonary reactions in patients with diabetes than other ACE inhibitors or angiotensin receptor blockers (ARBs). ACE inhibitors are commonly used to treat heart and kidney conditions, which are often comorbid with diabetes. A different ACE inhibitor may be a better […]
Many countries have enacted lockdowns in order to combat the spread of coronavirus (COVID-19). These stay-at-home orders have disrupted daily routines for many diabetes patients, which has created concerns over the possible consequences of added stress, isolation, and elevated blood sugars on glucose management. Read more
Dexcom’s G6 Pro CGM seeks to increase use in people with prediabetes through its “blinded” mode. The G6 Pro, which consists of a sensor and transmitter unit, can store up to 10 days of glucose readings on the transmitter. These readings can then be read and analyzed retrospectively by a health care professional. Read more
Tandem Diabetes has announced it has acquired Sugarmate, a popular app for people with diabetes who use insulin. The app allows patients to track of glucose levels and health/nutrition information, and notifies users and care providers about any fluctuation. For now, Sugarmate will continue to operate as a standalone entity and continue to provide services […]
It’s been well documented since the coronavirus pandemic began that people who have diabetes are at greater risk of severe complications and death from COVID-19. However, some researchers now say the relationship goes both ways: people who have been infected with COVID-19 are at risk of developing stress-related diabetes. Read more
Diabetic retinopathy, a common complication of diabetes, is a major cause of blindness in adults. A new study found that visual function in diabetic mice was significantly improved after treatment with a single dose of visual chromophore 9-cis-retinal, a vitamin A analog that can form a visual pigment in the retina cells, thereby producing a […]
A new study of body mass index (BMI) and end-stage renal disease (ESRD) suggests obesity may provide a health benefit when it comes to ESRD. The results, from a large Korean study, are surprising and differ from those of earlier studies. Read more
Black Americans must be recruited more actively for clinical trial participation, a researcher urges. Data from diabetes clinical trials show that findings often do not apply to blacks and other ethnic minorities in the same way they do to white diabetes patients. Read more
As researchers seek more knowledge of COVID-19 and why it is so deadly for some patients, studies have found that hypertension, obesity, and diabetes are among the most prevalent comorbidities (that is, conditions that co-exist with the primary disease) in patients with COVID-19. Read more
A new study of diabetes treatment in the United Kingdom has found treatment inertia is greater for black and South Asian type 2 diabetes patients than it is for white people with type 2. The term “treatment inertia” means health professionals are slow to increase the intensity of treatment (such as a raising the medication […]
Metabolic syndrome, which refers to a person having at least three inflammation risk factors such as hyperlipidemia, insulin resistance, and obesity, is common in people with diabetes. Lower extremity arterial disease, which involves the narrowing or clogging of the arteries leading to a gradual reduction of blood supply to the lower limbs, can result in increased […]
Researchers have identified metabolites in the blood that accurately predict whether a woman who has gestational diabetes during her pregnancy will go on to develop type 2 diabetes years later. This means a test could potentially be developed to help doctors identify those patients at greatest risk and possibly avert the disease through lifestyle interventions. […]
Adults who have diabetes are twice as likely to die from heart disease and stroke than people without diabetes, and younger people with diabetes will develop heart disease earlier than people without diabetes if they do not take steps to manage their risk. Read more
A recent study has found that elevated pre-pregnancy hemoglobin A1c, which measures average blood glucose concentration, is associated with higher risk of adverse pregnancy outcomes, even in women who have not been diagnosed with diabetes. Read more
A new study investigated whether being born prematurely can raise a person’s risks of developing either type 1 or type 2 diabetes from childhood into early to mid-adulthood. Read more
Blood glucose monitors were a breakthrough that helped people with diabetes manage their condition, and dominated glucose monitoring for over 50 years. But they may soon be replaced by continuous glucose monitors (CGM) which offer many advantages, including detecting how much time people spend in glucose control range. Read more
Daily foot self-inspections are thought to reduce the number of lower limb amputations in people with diabetes. Researchers compared data across different racial groups to see how foot inspections impacted amputations, and found that various other racial groups had a higher incidence of daily foot self-inspections than Caucasians. Read on
Both men and women are affected by diabetes, but previous studies have found that women are more affected by macrovascular complications such as coronary artery disease and stroke. It’s not yet known why this is, but the different ways male and female bodies store fat may play a role. Read more
A clinical trial is being conducted by the pharma company AstraZeneca and Saint Luke’s Mid America Heart Institute in Kansas City in which hospitalized COVID-19 patients are given the diabetes drug Farxiga. The blood-sugar-lowering effects of the drug cannot combat the coronavirus itself, but researchers are looking for signs it may reduce the risk of some […]
The Centers for Disease Control and Prevention (CDC) has noted that people with diabetes are at increased risk for severe complications if they contract COVID-19, but the agency has not addressed whether people with type 1 face different risk than those with type 2 diabetes. Now researchers are launching a study to look specifically at […]
